You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Medical Care

Global Oncology Anti-Cancer Drugs Market Analysis 2016-2020 and Forecast 2021-2026

Snapshot
The global Oncology Anti-Cancer Drugs market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Oncology Anti-Cancer Drugs by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Chemotherapy
Targeted Therapy
Immunotherapy (Biologic Therapy)
Hormonal Therapy
Others
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
Amgen
AstraZeneca
Roche Diagnostics
GlaxoSmithKline
Merck
Novartis
AbbVie
Sanofi
EIMC United Pharmaceuticals
Actavis
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Blood Cancer (Leukaemia)
Breast Cancer
Gastrointestinal Cancer
Respiratory/Lung Cancer
Skin Cancer
Other Cancers
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Table of Contents
1 Industry Overview
1.1 Oncology Anti-Cancer Drugs Industry
Figure Oncology Anti-Cancer Drugs Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Oncology Anti-Cancer Drugs
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Oncology Anti-Cancer Drugs
1.2.2 Downstream
Table Application Segment of Oncology Anti-Cancer Drugs
Table Global Oncology Anti-Cancer Drugs Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Oncology Anti-Cancer Drugs Market by Type
3.1 By Type
3.1.1 Chemotherapy
Table Major Company List of Chemotherapy
3.1.2 Targeted Therapy
Table Major Company List of Targeted Therapy
3.1.3 Immunotherapy (Biologic Therapy)
Table Major Company List of Immunotherapy (Biologic Therapy)
3.1.4 Hormonal Therapy
Table Major Company List of Hormonal Therapy
3.1.5 Others
Table Major Company List of Others
3.2 Market Size
Table Global Oncology Anti-Cancer Drugs Market 2016-2020, by Type, in USD Million
Figure Global Oncology Anti-Cancer Drugs Market Growth 2016-2020, by Type, in USD Million
Table Global Oncology Anti-Cancer Drugs Market 2016-2020, by Type, in Volume
Figure Global Oncology Anti-Cancer Drugs Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global Oncology Anti-Cancer Drugs Market Forecast 2021-2026, by Type, in USD Million
Table Global Oncology Anti-Cancer Drugs Market Forecast 2021-2026, by Type, in Volume
4 Major Companies List
4.1 Amgen (Company Profile, Sales Data etc.)
4.1.1 Amgen Profile
Table Amgen Overview List
4.1.2 Amgen Products & Services
4.1.3 Amgen Business Operation Conditions
Table Business Operation of Amgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 AstraZeneca (Company Profile, Sales Data etc.)
4.2.1 AstraZeneca Profile
Table AstraZeneca Overview List
4.2.2 AstraZeneca Products & Services
4.2.3 AstraZeneca Business Operation Conditions
Table Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Roche Diagnostics (Company Profile, Sales Data etc.)
4.3.1 Roche Diagnostics Profile
Table Roche Diagnostics Overview List
4.3.2 Roche Diagnostics Products & Services
4.3.3 Roche Diagnostics Business Operation Conditions
Table Business Operation of Roche Diagnostics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 GlaxoSmithKline (Company Profile, Sales Data etc.)
4.4.1 GlaxoSmithKline Profile
Table GlaxoSmithKline Overview List
4.4.2 GlaxoSmithKline Products & Services
4.4.3 GlaxoSmithKline Business Operation Conditions
Table Business Operation of GlaxoSmithKline (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Merck (Company Profile, Sales Data etc.)
4.5.1 Merck Profile
Table Merck Overview List
4.5.2 Merck Products & Services
4.5.3 Merck Business Operation Conditions
Table Business Operation of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Novartis (Company Profile, Sales Data etc.)
4.6.1 Novartis Profile
Table Novartis Overview List
4.6.2 Novartis Products & Services
4.6.3 Novartis Business Operation Conditions
Table Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 AbbVie (Company Profile, Sales Data etc.)
4.7.1 AbbVie Profile
Table AbbVie Overview List
4.7.2 AbbVie Products & Services
4.7.3 AbbVie Business Operation Conditions
Table Business Operation of AbbVie (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Sanofi (Company Profile, Sales Data etc.)
4.8.1 Sanofi Profile
Table Sanofi Overview List
4.8.2 Sanofi Products & Services
4.8.3 Sanofi Business Operation Conditions
Table Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 EIMC United Pharmaceuticals (Company Profile, Sales Data etc.)
4.9.1 EIMC United Pharmaceuticals Profile
Table EIMC United Pharmaceuticals Overview List
4.9.2 EIMC United Pharmaceuticals Products & Services
4.9.3 EIMC United Pharmaceuticals Business Operation Conditions
Table Business Operation of EIMC United Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 Actavis (Company Profile, Sales Data etc.)
4.10.1 Actavis Profile
Table Actavis Overview List
4.10.2 Actavis Products & Services
4.10.3 Actavis Business Operation Conditions
Table Business Operation of Actavis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Oncology Anti-Cancer Drugs Sales Revenue 2016-2020, by Company, in USD Million
Table Global Oncology Anti-Cancer Drugs Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Oncology Anti-Cancer Drugs Sales Revenue Share in 2020, by Company, in USD Million
Table Global Oncology Anti-Cancer Drugs Sales Volume 2016-2020, by Company, in Volume
Table Global Oncology Anti-Cancer Drugs Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Oncology Anti-Cancer Drugs Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America Oncology Anti-Cancer Drugs Market Concentration, in 2020
Figure Europe Oncology Anti-Cancer Drugs Market Market Concentration, in 2020
Figure Asia-Pacific Oncology Anti-Cancer Drugs MMarket Concentration, in 2020
Figure South America Oncology Anti-Cancer Drugs Market Concentration, in 2020
Figure Middle East & Africa Oncology Anti-Cancer Drugs Market Concentration, in 2020
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Blood Cancer (Leukaemia)
Figure Oncology Anti-Cancer Drugs Demand in Blood Cancer (Leukaemia), 2016-2020, in USD Million
Figure Oncology Anti-Cancer Drugs Demand in Blood Cancer (Leukaemia), 2016-2020, in Volume
6.1.2 Demand in Breast Cancer
Figure Oncology Anti-Cancer Drugs Demand in Breast Cancer, 2016-2020, in USD Million
Figure Oncology Anti-Cancer Drugs Demand in Breast Cancer, 2016-2020, in Volume
6.1.3 Demand in Gastrointestinal Cancer
Figure Oncology Anti-Cancer Drugs Demand in Gastrointestinal Cancer, 2016-2020, in USD Million
Figure Oncology Anti-Cancer Drugs Demand in Gastrointestinal Cancer, 2016-2020, in Volume
6.1.4 Demand in Respiratory/Lung Cancer
Figure Oncology Anti-Cancer Drugs Demand in Respiratory/Lung Cancer, 2016-2020, in USD Million
Figure Oncology Anti-Cancer Drugs Demand in Respiratory/Lung Cancer, 2016-2020, in Volume
6.1.5 Demand in Skin Cancer
Figure Oncology Anti-Cancer Drugs Demand in Skin Cancer, 2016-2020, in USD Million
Figure Oncology Anti-Cancer Drugs Demand in Skin Cancer, 2016-2020, in Volume
6.1.6 Demand in Other Cancers
Figure Oncology Anti-Cancer Drugs Demand in Other Cancers, 2016-2020, in USD Million
Figure Oncology Anti-Cancer Drugs Demand in Other Cancers, 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Oncology Anti-Cancer Drugs Demand Forecast 2021-2026, by Application, in USD Million
Figure Oncology Anti-Cancer Drugs Market Growth 2021-2026, by Application, in USD Million
Figure Oncology Anti-Cancer Drugs Market Share in 2026, by Application, in USD Million
Table Oncology Anti-Cancer Drugs Demand Forecast 2021-2026, by Application, in Volume
Table Oncology Anti-Cancer Drugs Market Growth 2021-2026, by Application, in Volume
Table Oncology Anti-Cancer Drugs Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table Oncology Anti-Cancer Drugs Production 2016-2020, by Region, in USD Million
Table Oncology Anti-Cancer Drugs Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global Oncology Anti-Cancer Drugs Market 2016-2020, by Region, in USD Million
Table Global Oncology Anti-Cancer Drugs Market Share 2016-2020, by Region, in USD Million
Table Global Oncology Anti-Cancer Drugs Market 2016-2020, by Region, in Volume
Table Global Oncology Anti-Cancer Drugs Market Share 2016-2020, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Oncology Anti-Cancer Drugs Market Size and Growth 2016-2020, in USD Million
Figure North America Oncology Anti-Cancer Drugs Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Oncology Anti-Cancer Drugs Market Size 2016-2020, by Country, in USD Million
Table North America Oncology Anti-Cancer Drugs Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Oncology Anti-Cancer Drugs Market Size and Growth 2016-2020, in USD Million
Figure Europe Oncology Anti-Cancer Drugs Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Oncology Anti-Cancer Drugs Market Size 2016-2020, by Country, in USD Million
Table Europe Oncology Anti-Cancer Drugs Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Oncology Anti-Cancer Drugs Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Oncology Anti-Cancer Drugs Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Oncology Anti-Cancer Drugs Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Oncology Anti-Cancer Drugs Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Oncology Anti-Cancer Drugs Market Size and Growth 2016-2020, in USD Million
Figure South America Oncology Anti-Cancer Drugs Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Oncology Anti-Cancer Drugs Market Size 2016-2020, by Country, in USD Million
Table South America Oncology Anti-Cancer Drugs Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Oncology Anti-Cancer Drugs Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Oncology Anti-Cancer Drugs Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Oncology Anti-Cancer Drugs Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Oncology Anti-Cancer Drugs Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Oncology Anti-Cancer Drugs Market Forecast 2021-2026, by Region, in USD Million
Table Oncology Anti-Cancer Drugs Market Forecast 2021-2026, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion
  • FORMAT: PDF
  • PUBLISHED DATE: Apr, 2021
  • NO OF PAGES: 87